Effects of Phytosterol Supplementation on Serum Levels of Lipid Profiles, Liver Enzymes, Inflammatory Markers, Adiponectin, and Leptin in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Mohammad Ali JavanmardiMohammad Shahi MajidSeyed Saeed SeyedianMohammad Hossein HaghighizadehPublished in: Journal of the American College of Nutrition (2018)
The present study suggested that daily consumption of 1.6 g phytosterols efficiently lowers low-density lipoprotein cholesterol, aspartate aminotransferase, alanine aminotransferase, and tumor necrosis factor alpha in patients with nonalcoholic fatty liver disease.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- double blind
- placebo controlled
- rheumatoid arthritis
- peritoneal dialysis
- prognostic factors
- insulin resistance
- physical activity
- clinical trial
- fatty acid
- radiation therapy
- liver fibrosis
- patient reported outcomes
- adipose tissue
- rectal cancer
- phase ii
- patient reported